SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Corbus Pharmaceuticals PT maintained at $35 by HC Wainwright

HC Wainwright & Co. maintained its $35.00 per share price target for Corbus Pharmaceuticals, according to Benzinga ratings actions.

CRBP

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories